Viewpoint: Why do we need a point-of-care CD4 test for low-income countries?

Trop Med Int Health. 2011 Jan;16(1):37-41. doi: 10.1111/j.1365-3156.2010.02669.x. Epub 2010 Nov 2.

Abstract

In this paper, we discuss the reasons why we urgently need a point-of-care (POC) CD4 test, elaborate the problems we have experienced with the current technology which hampers CD4-count coverage and highlight the ideal characteristics of a universal CD4 POC test. It is high-time that CD4 technology is simplified and adapted for wider use in low-income countries to change the current paradigm of restricted access once and for all.

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count*
  • Developing Countries*
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • Health Services Accessibility
  • Health Services Needs and Demand*
  • Humans
  • Point-of-Care Systems*

Substances

  • Anti-HIV Agents